Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,825.20
(
-0.50%
)
Dow Jones
49,447.43
(
1.88%
)
Brent Oil
91.62
(
-1.12%
)
Bitcoin
75,196.06
(
1.81%
)
News Focus
News Focus
Post# of 257426
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122876
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 96361

Tuesday, 05/25/2010 5:16:10 PM

Tuesday, May 25, 2010 5:16:10 PM

Post# of 257426
One Telaprevir patient in the ADVANCE study developed Stevens-Johnson Syndrome, but this was not judged to be Telaprevir-related because SJS emerged 11 weeks after the patient completed the regimen of Telaprevir.

There had been rumors for the past year or so that one Telaprevir patient had developed a devastating rash; now we know what the rumors stemmed from.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today